European Journal of Drug Metabolism and Pharmacokinetics

Title Publication Date Language Citations
Metabolism and metabolite pharmacokinetics of BRB-I-28, a class Ib antiarrhythmic agent1995/06/01English
Letter to the Editor2005/03/01English
Evaluation of the excretion, and metabolism of the cardiotonic agent bemoradan in male rats and female beagle dogs2001/12/01English
An overview about Biopharmaceutics in Europe2005/03/01English
Metabolism of the new α-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats2005/03/01English
Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs2005/03/01English
[2-14C]Thymidine incorporation activity of stem cells in either tumor or cradle tissues in a normal or transplanted animals2005/03/01English
Pharmacokinetics of lidocaine and its major metabolite — monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction1995/06/01English
Detection and mass spectrometric characterization of the major urinary and fecal metabolites of 9-methyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]-quinolizine in the rat1995/06/01English
Editorial2005/03/01English
Detection of nimesulide metabolites in rat plasma and hepatic subcellular fractions by HPLC-UV/DAD and LC-MS/MS studies2005/03/01English
The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens2005/03/01English
Metabolism of the α-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 factions -API-MS/MS identification of metabolites2005/03/01English
Prediction of drug clearance in humans from laboratory animals based on body surface area2001/12/01English
Induction of hepatic and presystemic metabolism of antipyrine in the mice: Rifampicin versus rifabutin2001/12/01English
Developmental pharmacology and toxicology: Biotransformation of drugs and other xenobiotics during postnatal development2005/03/01English
Pharmacokinetics and toxicity of idarubicin in the rat2001/12/01English
Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes2001/12/01English
Statistical aspects of bioequivalence testing between two medicinal products2005/03/01English
Events2001/12/01English
Events2005/03/01English
Erratum to: Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma1995/06/01English
Transport of thalidomide by the human intestinal Caco-2 monolayers2005/03/01English
Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or “TEER, a measurement of toxicity ?”2005/03/01English
Urinary excretion of the 1,4-dihydropyridine calcium antagonist VULM 993 and its metabolites in the rat2001/12/01English
Differential effect of cancer on the serum protein binding of mianserin and imipramine1995/06/01English
Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation2005/03/01English
In vitro andin vivo metabolism of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate2005/03/01English
Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats2005/03/01English
Rapid determination of functional liver plasma flow in ICU patients by a modified hepatic D-sorbitol plasma clearance method1993/12/01English